glp-1 receptor agonist weight loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Agonists Interest in Treatment with GLP-1

The half-life of these drugs varies widely (see table below) from two weeks with the extended-release form of exenatide (Bydureon Bcise), which is injected weekly, to thirteen hours for the daily injected liraglutide (Victoza, Saxenda)

Our survey found that over 75% of health plans and over 50% of employers are moderately or very concerned about off-label use, but awareness of how much current spend is off-label is notably lower: nearly half of employers and a quarter of health plans are unsure

2020 Jan:151:104554

They are not intended for human or animal consumption, injection, ingestion, topical use, self-experimentation, performance enhancement, or therapeutic use

Conventional 2D in vitro BBB models typically utilize either patient-derived primary brain endothelial cells (BECs) or commercially available immortalized BEC cell lines 44,45,46